Navigation Links
Solid tumor cells not killed by radiation and chemotherapy become stronger
Date:6/9/2008

DURHAM, N.C. Because of the way solid tumors adapt the body's machinery to bring themselves more oxygen, chemotherapy and radiation may actually make these tumors stronger.

"In a sense, these therapies can make the tumor healthier," said Mark W. Dewhirst, D.V.M., Ph.D., professor of radiation oncology at Duke University Medical Center. "Unless the treatment is very effective in killing many if not most tumor cells, you are shooting yourself in the foot."

Dewhirst and colleagues Yiting Cao, M.D., Ph.D., of Duke Pathology, and Benjamin Moeller, M.D., Ph.D. have introduced this counter-intuitive idea at recent conferences and in a review article featured in the June issue of Nature Reviews Cancer.

Radiation and chemotherapy do kill most solid tumor cells, but in the cells that survive, the therapies drive an increase in a regulatory factor called HIF1 (hypoxia-inducible factor 1), which cells use to get the oxygen they need by increasing blood vessel growth into the tumor. Solid tumors generally have low supplies of oxygen, Dewhirst explained and HIF1 helps them get the oxygen they need.

The review article concludes that blocking HIF1 would provide a clear mechanism for killing solid-tumor cells, particularly cells that are proving resistant to radiation or chemotherapy treatments.

As a part of this work, Dewhirst's team has been studying the phenomenon of rising and falling oxygen levels in tumors, called cycling hypoxia. Oxygen levels have been found to naturally cycle up and down in individual blood vessels as well as large tumor regions. This instability in the tumor's oxygen levels can increase HIF-1 production and cause radiation therapy to fail, Dewhirst said.

"It is my opinion that the whole tumor grows more aggressively because of this pulsation of oxygen at low levels," Dewhirst said. "Most people thought cycling hypoxia was caused by temporary stoppage of blood flow in single blood vessel in
'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MedAmerica Reports Solid Growth, Outperforms Industry
2. Insurance Department to Hold Statewide Meetings on Proposed Consolidation of Independence Blue Cross, Highmark
3. STAAR Surgical Reports Solid First Quarter Progress
4. Life Sciences Discovery Fund Awards $2.2 Million to Support New Solid-Tumor Research Program
5. A long-term survival offered by resection of solid-pseudopapillary tumor of the pancreas?
6. New target for cancer therapy may improve treatment for solid tumors
7. Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
8. Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
9. SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services
10. Insurance Department Will Hold Public Hearings on Proposed Consolidation of Highmark, Independence Blue Cross
11. James E. Harris to Become Chief Financial Officer of Coca-Cola Bottling Co. Consolidated

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...INE, Calif., Dec. 1 Mas...imetry(TM) and Measure-Through Motion and Low Perf...e of its latest innovation -- Masimo Rainbow SET A...and continuous respiration rate (RRa(TM)) that is ...ance. Masimo Rainbow SET Acoustic Monitoring may ...
(Date:12/1/2009)... Craig Moskowitz, a fourth-year medical student at...o go into internal medicine to help fulfill an unm...k, NJ (PRWEB) December 1, 2009 -- Having distingui...censing examinations, Craig Moskowitz--a fourth-ye...dicine--knew he could go into any area of medicine...
(Date:12/1/2009)... Anthony M. Marlon, MD was elected to the Stemedic...) Board of Directors at the Company’s Novemb...(PRWEB) December 1, 2009 -- Anthony M. Marlon, MD ...Inc. (“Stemedica”) Board of Directors .... Roger J. Howe, PhD, Executive Chairman for Steme...
(Date:12/1/2009)... Dec. 1 "The patient will see you ...Blue Cross and Blue Shield of Minnesota,s 10,000 e...rst Minnesotans - and the first in the continental.... Online Care Anywhere allows patients to access m...to a computer or picking up the phone. Blue Cross ...
(Date:12/1/2009)...tion from annual mammography screening may increas...lial predisposition to breast cancer, according to...the Radiological Society of North America (RSNA). ...reening is very important, but a careful approach ...creening young women, particularly under age 30," ...
Breaking Medicine News(10 mins):Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6Health News:Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3Health News:Mammography may increase breast cancer risk in some high-risk women 2
...., Jan. 12 Alseres Pharmaceuticals, Inc. today a...ce from the NASDAQ Stock Market ("NASDAQ") that fo... value of its listed securities has been below the... comply with NASDAQ Marketplace Rule 4310(c)(3)(A)...
...w Have Access to Advanced Medical Expertise When F... NEW YORK, Jan. 12 Nippon Life Benefits, a leadin...ompanies, today announced that its members will ha... , , The new service will allow eligible employe...
... Va., Jan. 12, 2009 AMERIGROUP Corporation (NYSE:...he AMERIGROUP Public Policy Institute, which will ...althcare programs and initiatives that serve peopl...of AMERIGROUP Corporation and the AMERIGROUP Found...
... Affiliated Computer Services, Inc. (NYSE: ACS ...h Health Savings Account (HSA) administration serv...lect counties of Washington. Regence members will .../Intermountain region, ACS now offers the ACS HSA ...
...The Netherlands, January 12 , - Small and Com...care and,Hospitality , With the introduction o...nd easily wearable wireless messaging device, NEC ...com.com/cgi-bin/prnh/20090112/333834 ) , The ...
...ne, the only publication of its kind aimed at heal...12 HealthCare Insight(R) (HCI), a Verisk HealthCa...fraud, abuse, and overpayment prevention solutions...rehensive publication dedicated to helping public ...
Other Medicine News:Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 2Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 3Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 4Health News:Nippon Life Benefits Partners with Best Doctors to Help Members Make More Informed Health Care Decisions 2Health News:Nippon Life Benefits Partners with Best Doctors to Help Members Make More Informed Health Care Decisions 3Health News:AMERIGROUP to Establish Public Policy Institute 2Health News:AMERIGROUP to Establish Public Policy Institute 3Health News:ACS to Provide HSA Product to Regence; ACS HSA Solution Now Offered by Blue Cross Blue Shield Plans in 28 States 2Health News:NEC's new M155 Messenger Sets New Standards in Mobile Messaging 2Health News:HealthCare Insight(R) Launches Industry Fraud Magazine 2
(Date:12/1/2009)...Dec. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (...ical products in China, announced today that,it ha...vaccine, PANFLU.1(TM),from China,s Ministry of In...,purchase plan. Under this purchase order, Sinovac...doses of PANFLU.1 (TM) (15ug/0.5ml) for the Chines...
(Date:12/1/2009)...ec. 1 Sagent Pharmaceuticals, Inc....y, today announced the launch of two antibiotics: ...njection, USP. Both are antibiotics of the cephalo...ive and gram-negative bacteria. Sagent will launch...ent the four vial sizes launched by Sagent in July...
(Date:12/1/2009)...lif., Dec. 1 Codexis, Inc. today a...signing of its second agreement this year with Tev...est generic drug manufacturer. The new agreement ... Codexis announced an earlier agreement with Teva ...will use Codexis biocatalysis technology for key p...
Breaking Medicine Technology:Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2Codexis Expands Collaboration with Teva 2Tips To Enjoy a Flu Free Holiday Season 62071 1Tips To Enjoy a Flu Free Holiday Season 62071 2Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 62067 1Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 62067 2Union Labor Life 26amp 3B VSP Vision Care Align to Offer Vision Insurance Products 62063 1Union Labor Life 26amp 3B VSP Vision Care Align to Offer Vision Insurance Products 62063 2
...I) (Nasdaq and MTA: CTIC) announced that data from...pixantrone in patients with advanced, relapsed agg...nted at the 2009 American Society of Clinical Onco...m May 29 to June 2, 2009 in Orlando, Florida. , ,...niversity of London, an investigator on the study,...
...(Nasdaq: SPEX ), an innovator in biotechnology f...nd regulatory consulting services to food, supplem...oday announced that, on May 12, 2009, its Board of...omas B. Peter, to begin serving immediately. Mr. ...n and Nominating Committees. , , Spherix,s Nomina...
Other Medicine Technology:Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting 2Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting 3Spherix Elects New Independent Director, and Elects Chairman of the Board 2Spherix Elects New Independent Director, and Elects Chairman of the Board 3
Legionella IgG/M II ELISA
Epstein-Barr virus (EBV) ELISA
HSV Group IgG ELISA
CMV IgG II ELISA
Medicine Products: